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Volume 53, Number 17S Abstracts 109SResults: 30 patients [26 men, median age 75 years
(IQR: 68-78)] were included in the study. Median Anaer-
obic threshold was 12.67 ml/min/kg (IQR: 8.6-16.42).
Median hospital stay was 7 days (IQR: 5-12), post opera-
tive complications were observed in 10% (n3) and mor-
tality rate was 7% (n2).
Inter-group Analysis: There was a significant difference
(P0.042) between the two groups in the AT [median AT,
Alive: 12.76 ml/min/kg (range; 5.52-22.37), Dead: 6.67
ml/min/kg (range; 6.08-7.26)]. However, there was no
statistically significant difference between the two groups
for basic demographics, co-morbidities and pre-operative
medications.
Conclusions:Anaerobic threshold in cardiopulmonary
exercise testing may be used as an independent predictor of
outcome in patients undergoing AAA repair. Further stud-
ies are required to establish its role as an independent
predictor of morbidity & mortality in elective AAA
patients.
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Objectives: Most endovenous techniques for treatment
of great saphenous vein incompetence use thermal energy,
which requires instillation of tumescence anaesthesia andmay
lead to heat-related nerve damage. The innovative mechano-
chemical endovenous ablation (MECEA) of the great and
small saphenous veinwas recently developed to induces occlu-
sion by endovenous mechanical damage combined with infu-
sion of a liquid sclerosans. Initial results.
Methods: Prospective study of 110 consecutive pa-
tients, treated for 126 insufficient veins withMECEA using
ClariVeinTM device (Vascular Insights, USA) and aetox-
ysklerol. Initial technical success (obliteration at post-pro-
cedural duplex scan), complications, patient satisfaction
and visual analogue scale painscore (VAS) were assessed.
Follow up included duplex scan of treated veins.
Inclusion criteria: 1. Venous incompetence of GSV,
SSV or anterolateral side branches (ASB). 2. Vein diameter
of 3 to 11mm. 3. Length of incompetence  15 cm.
Results: From June to December 2010 126 legs were
treated (107 GSV, 13 SSV, 6 ASB). The median length of
treated veins was 37cm (16-52). Initial technical success of fECEA was 100%. Median (VAS) painscore was 3 (0-10).
o nerve damage occurred. The majority of patients al-
eady had 6 weeks follow-up duplex scan: 76 of 77 patients
98%) had obliteration of the treated vein. In one patient
otal recanalisation occurred, she had successful renewed
ECEA. Four patients had 6 months duplex scans and all
eins remained obliterated. No patients suffered from ma-
or complications; local hematoma at the puncture site was
een in 26%and superficial trombophlebitis in 23%, resolv-
ng within a week.
Conclusions: Mechanochemical obliteration of long
egment GSV, SSV and ASB incompetence is feasible with
00% initial technical success in this first large series. VAS
cores are low and no tumescent anesthesia is necessary.
hort-term follow-up is encouraging, and a Dutch registry
as been started to gather longer-term follow-up.
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Objectives: We assessed the impact of endovenous
blation of incompetent veins on the healing rate of venous
lcers in patients who had failed conventional compression
herapy.
Methods: Venous disease was CEAP classified. Pa-
ients with CEAP 6 ulcers were treated with weekly com-
ression in a dedicated wound care center. Ulcer size and
epth were tracked prospectively. Those ulcers that showed
o measurable improvement after 5 weeks of compres-
ion therapy underwent ablation of at least one incompe-
ent vein.
Results: We performed 140 consecutive endovenous
blation procedures (74 axial and 66 perforating) on 110
enous ulcers in 88 limbs. Ulcers had been present for
16mo with an initial ulcer area of 236 cm2. Following
uccessful ablation, the healing rate for healed ulcers im-
roved from 3.49.4%/mo to 75.526.3%/mo
p0.001)(Fig 1). Healing rate by vein ablation location
as: GSV6.4cm2/mo, SSV4.8cm2/mo, posterior tib-
al perforator veins2.9cm2/mo. After a minimum obser-
ation period of 4.5 months (mean follow-up 111.25
o), 84% of patients healed in 14214 days. Twelve
atients with 26 ulcers did not heal (Fig 2): 2 patients died
rom unrelated illnesses, 6 patients are still actively healing,
